Bachelor of science in chemistry, Truman State University, which included undergraduate research involving the synthesis of N-methylbenzohydroxamates and the subsequent investigation of the effect of substituent variation on their nucleophilicity via the α-effect by electrochemical and NMR methods, and the correlation with single electron characteristics in reaction transition state.
Master of science in chemistry with an emphasis on synthetic organic chemistry, University of North Carolina, Chapel Hill; completed my thesis on the synthesis, characterisation, and structural interpretation of novel 1,3,4-oxadiazole bearing bent-core liquid crystals.
Have worked in the pharmaceutical industry since grad school, working on a wide range of research projects that include the synthesis and conjugation of insulin-bearing PEG conjugates; the development and synthesis of novel small molecule pharmaceutical candidates; the development of differential scanning calorimetry methods for the testing of pharmaceutical compounds; and the development of large-scale column chromatographic methods for the purification of proteinaceous vaccine components derived from genetically engineered microorganisms.
And, I am able to spell the phrase "bona fides."
So what are yours?
But, but, you don’t have a Ph.D.! Kent Hovind has one, so he’s more believable.
Oh, and you can thank FR's crappy spell check for the weird bona fides incident.
Interesting credentials.
Do you believe the earth to be less than 10,000 years old?